Hfm Investment Advisors, LLC Immunity Bio, Inc. Transaction History
Hfm Investment Advisors, LLC
- $227 Billion
- Q2 2025
A detailed history of Hfm Investment Advisors, LLC transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Hfm Investment Advisors, LLC holds 4 shares of IBRX stock, worth $12. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4
Previous 6
33.33%
Holding current value
$12
Previous $19,000
42.11%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding IBRX
# of Institutions
246Shares Held
80.5MCall Options Held
1.09MPut Options Held
2.73M-
Vanguard Group Inc Valley Forge, PA20.3MShares$61.2 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$34.4 Million0.0% of portfolio
-
State Street Corp Boston, MA7.58MShares$22.8 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA4.29MShares$12.9 Million0.0% of portfolio
-
Woodline Partners LP San Francisco, CA3.45MShares$10.4 Million0.07% of portfolio
About ImmunityBio, Inc.
- Ticker IBRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 400,304,000
- Market Cap $1.2B
- Description
- ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...